Filing Flows › Colgate Palmolive (CL) › Q2 2026 › vs Q1 2026
Colgate Palmolive (CL) Q2 2026 vs Q1 2026 (quarter over quarter)
Colgate Palmolive's revenue rose $37.0M (+0.7%) from $5.3B in Q1 2026 to $5.4B in Q2 2026. Gross margin 61.5% against 60.6% (+0.9 pts).
Colgate Palmolive, Q2 2026: revenue $5.4B (+5% year over year), operating margin 19.0%, net earnings $693M, operating cash flow $995M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Gross margin | 61.5% | 60.6% | +0.9 pts |
| Operating margin | 19.0% | 18.1% | +0.8 pts |
| Net margin | 12.9% | 12.1% | +0.8 pts |
| Free cash flow margin | 16.2% | 11.4% | +4.7 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $5.4B | $5.3B | $37.0M | +0.7% |
| Gross profit | $3.3B | $3.2B | $70.0M | +2% |
| Cost of revenue | $2.1B | $2.1B | −$33.0M | -2% |
| Operating profit | $1.0B | $964M | $52.0M | +5% |
| Operating expenses | $2.3B | $2.3B | $18.0M | +0.8% |
| Pre-tax earnings | $950M | $892M | $58.0M | +7% |
| Other expense, net | $66.0M | $72.0M | −$6.0M | -8% |
| SG&A | $2.1B | $2.1B | $54.0M | +3% |
| Other operating costs | $150M | $186M | −$36.0M | -19% |
| Net earnings | $693M | $646M | $47.0M | +7% |
| Minority interests | $26.0M | $35.0M | −$9.0M | -26% |
| Income tax | $231M | $211M | $20.0M | +9% |
| Depreciation & amortization | $155M | $156M | −$1.0M | -0.6% |
| Share-based compensation | $38.0M | $40.0M | −$2.0M | -5% |
| Working capital & other | $109M | −$95.0M | $204M | — |
| Operating cash flow | $995M | $747M | $248M | +33% |
| Free cash flow (OCF − capex) | $867M | $609M | $258M | +42% |
| Capital expenditures | $128M | $138M | −$10.0M | -7% |
Questions
How much did Colgate Palmolive's revenue grow quarter over quarter in Q2 2026?
Colgate Palmolive's revenue rose $37.0M (+0.7%) from $5.3B in Q1 2026 to $5.4B in Q2 2026. Gross margin 61.5% against 60.6% (+0.9 pts).